- Author
- Jan Stautemas (UGent) , Inge Everaert (UGent) , Filip Lefevere and Wim Derave (UGent)
- Organization
- Abstract
- Introduction: The ergogenic response following long-term ingestion of beta-alanine shows a high inter-individual variation. It is hypothesized that this variation is partially caused by a variable pharmacokinetic response induced by inferior dosing strategies. At this point most supplements are either taken in a fixed amount (x g), as is the case with beta-alanine, or relative to body weight (x g per kg BW), but there is currently neither consensus nor a scientific rationale on why these or other dosing strategies should be used. The aim of this study is to objectify and understand the variation in plasma pharmacokinetics of a single oral b-alanine dose supplemented as either a fixed or a weight-relative dose (WRD) in an anthropometric diverse sample. Methods: An anthropometric diverse sample ingested a fixed dose (1,400mg) (n = 28) and a WRD of beta-alanine (10 mg/kg BW) (n = 34) on separate occasions. Blood samples were taken before and at nine time points (up to 4 h) after beta-alanine ingestion in order to establish a pharmacokinetic profile. Incremental area under the curve (iAUC) was calculated by the trapezoidal rule. Plasma beta-alanine was quantified using HPLC-fluorescence. Results: The variation coefficient (CV%) of the iAUC was 35.0% following ingestion of 1,400mg b-alanine. Body weight explained 30.1% of the variance and was negatively correlated to iAUC (r = -0.549; p = 0.003). Interestingly, the CV% did not decrease with WRD (33.2%) and body weight was positively correlated to iAUC in response to the WRD (r = 0.488; p = 0.003). Conclusion: Both dosing strategies evoked an equally high inter-individual variability in pharmacokinetic plasma profile. Strikingly, while body weight explained a relevant part of the variation observed following a fixed dose, correction for body weight did not improve the homogeneity in b-alanine plasma response. We suggest to put more effort into the optimization of easy applicable and scientifically justified personalized dosing strategies.
- Keywords
- beta-alanine, sports supplements, pharmacokinetics, personalized nutrition, carnosine, SKELETAL-MUSCLE, CARNOSINE, SUPPLEMENTATION, EXERCISE, PERFORMANCE, HISTIDINE, CAPACITY
Downloads
-
8585109.pdf
- full text
- |
- open access
- |
- |
- 873.61 KB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8576978
- MLA
- Stautemas, Jan, et al. “Pharmacokinetics of β-Alanine Using Different Dosing Strategies.” FRONTIERS IN NUTRITION, vol. 5, 2018, doi:10.3389/fnut.2018.00070.
- APA
- Stautemas, J., Everaert, I., Lefevere, F., & Derave, W. (2018). Pharmacokinetics of β-alanine using different dosing strategies. FRONTIERS IN NUTRITION, 5. https://doi.org/10.3389/fnut.2018.00070
- Chicago author-date
- Stautemas, Jan, Inge Everaert, Filip Lefevere, and Wim Derave. 2018. “Pharmacokinetics of β-Alanine Using Different Dosing Strategies.” FRONTIERS IN NUTRITION 5. https://doi.org/10.3389/fnut.2018.00070.
- Chicago author-date (all authors)
- Stautemas, Jan, Inge Everaert, Filip Lefevere, and Wim Derave. 2018. “Pharmacokinetics of β-Alanine Using Different Dosing Strategies.” FRONTIERS IN NUTRITION 5. doi:10.3389/fnut.2018.00070.
- Vancouver
- 1.Stautemas J, Everaert I, Lefevere F, Derave W. Pharmacokinetics of β-alanine using different dosing strategies. FRONTIERS IN NUTRITION. 2018;5.
- IEEE
- [1]J. Stautemas, I. Everaert, F. Lefevere, and W. Derave, “Pharmacokinetics of β-alanine using different dosing strategies,” FRONTIERS IN NUTRITION, vol. 5, 2018.
@article{8576978, abstract = {{Introduction: The ergogenic response following long-term ingestion of beta-alanine shows a high inter-individual variation. It is hypothesized that this variation is partially caused by a variable pharmacokinetic response induced by inferior dosing strategies. At this point most supplements are either taken in a fixed amount (x g), as is the case with beta-alanine, or relative to body weight (x g per kg BW), but there is currently neither consensus nor a scientific rationale on why these or other dosing strategies should be used. The aim of this study is to objectify and understand the variation in plasma pharmacokinetics of a single oral b-alanine dose supplemented as either a fixed or a weight-relative dose (WRD) in an anthropometric diverse sample. Methods: An anthropometric diverse sample ingested a fixed dose (1,400mg) (n = 28) and a WRD of beta-alanine (10 mg/kg BW) (n = 34) on separate occasions. Blood samples were taken before and at nine time points (up to 4 h) after beta-alanine ingestion in order to establish a pharmacokinetic profile. Incremental area under the curve (iAUC) was calculated by the trapezoidal rule. Plasma beta-alanine was quantified using HPLC-fluorescence. Results: The variation coefficient (CV%) of the iAUC was 35.0% following ingestion of 1,400mg b-alanine. Body weight explained 30.1% of the variance and was negatively correlated to iAUC (r = -0.549; p = 0.003). Interestingly, the CV% did not decrease with WRD (33.2%) and body weight was positively correlated to iAUC in response to the WRD (r = 0.488; p = 0.003). Conclusion: Both dosing strategies evoked an equally high inter-individual variability in pharmacokinetic plasma profile. Strikingly, while body weight explained a relevant part of the variation observed following a fixed dose, correction for body weight did not improve the homogeneity in b-alanine plasma response. We suggest to put more effort into the optimization of easy applicable and scientifically justified personalized dosing strategies.}}, articleno = {{70}}, author = {{Stautemas, Jan and Everaert, Inge and Lefevere, Filip and Derave, Wim}}, issn = {{2296-861X}}, journal = {{FRONTIERS IN NUTRITION}}, keywords = {{beta-alanine,sports supplements,pharmacokinetics,personalized nutrition,carnosine,SKELETAL-MUSCLE,CARNOSINE,SUPPLEMENTATION,EXERCISE,PERFORMANCE,HISTIDINE,CAPACITY}}, language = {{eng}}, pages = {{7}}, title = {{Pharmacokinetics of β-alanine using different dosing strategies}}, url = {{http://doi.org/10.3389/fnut.2018.00070}}, volume = {{5}}, year = {{2018}}, }
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: